Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.34
-0.13 (-2.01%)
Sep 4, 2026, 12:23 PM EDT - Market open
Teladoc Health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,489 | 2,530 | 2,570 | 2,602 | 2,407 | 2,033 |
Revenue Growth | -2.08% | -1.54% | -1.26% | 8.13% | 18.41% | 85.81% |
Gross Profit Gross Profit Growth | 1,717 | 1,758 | 1,818 | 1,842 | 1,663 | 1,382 |
Operating Income Operating Income Growth | -145.65 | -163.4 | -208.79 | -210.5 | -217.47 | -238.99 |
Net Income Net Income Growth | -177.4 | -200.32 | -1,001 | -220.37 | -13,660 | -428.79 |
Earnings Per Share EPS Growth | -0.99 | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Access Fees Access Fees Growth | 2,001 | 2,092 | 2,215 | 2,283 | 2,104 | 1,740 |
Other Source Other Source Growth | 488.11 | 438.04 | 354.35 | 319.89 | 303.03 | 292.54 |
Revenue (Total) Revenue (Total) Growth | 2,489 | 2,530 | 2,570 | 2,602 | 2,407 | 2,033 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 774.35 | 781.08 | 1,298 | 1,124 | 918.18 | 896.02 |
Total Debt Total Debt Growth | 1,036 | 1,040 | 1,585 | 1,592 | 1,587 | 1,303 |
Net Cash (Debt) Net Cash Growth | -261.86 | -259.08 | -286.29 | -468.6 | -668.74 | -406.72 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.47 | -1.47 | -1.68 | -2.85 | -4.14 | -2.59 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 261.18 | 294.36 | 293.68 | 350.02 | 189.29 | 193.99 |
Capital Expenditures CapEx Growth | -7.49 | -8.89 | -10.79 | -11.46 | -16.48 | -8.53 |
Free Cash Flow Free Cash Flow Growth | 253.7 | 285.46 | 282.89 | 338.56 | 172.81 | 185.46 |
Free Cash Flow Growth | -13.03% | 0.91% | -16.44% | 95.91% | -6.82% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.97% | 69.50% | 70.76% | 70.80% | 69.09% | 68.01% |
Operating Margin | -5.85% | -6.46% | -8.13% | -8.09% | -9.04% | -11.76% |
Pretax Margin | -7.33% | -9.31% | -38.67% | -8.44% | -567.69% | -18.92% |
Profit Margin | -7.13% | -7.92% | -38.96% | -8.47% | -567.53% | -21.09% |
FCF Margin | 10.19% | 11.28% | 11.01% | 13.01% | 7.18% | 9.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | 4.55 | 4.35 | 5.53 | 10.54 | 22.16 | 79.26 |
PS Ratio | 0.46 | 0.49 | 0.61 | 1.37 | 1.59 | 7.23 |